You are here

Pharmaceutical Approval Update September 2009

Marvin M. Goldenberg, PhD, RPh, MS
PDF version: 
Topics covered include prasugrel (Effient) for reducing cardiovascular events in patients with acute coronary syndrome; ferumoxytol injection (Feraheme) for iron-deficiency anemia in adults with chronic kidney disease; and dronedarone (Multaq) for the treatment of atrial fibrillation.